Fear of cancer recurrence in oncology follow-up: Prevalence and the role of patient–oncologist communication.

N Natalia Camejo (Servicio de Oncologia Clinica, Hospital de Clínicas, University of Uruguay, Montevideo, Uruguay) C Cecilia Castillo (Hospital de Clínicas, Montevideo, Uruguay) D Dahiana Amarillo (Hospital de Clinicas, Montevideo, Uruguay) G Guadalupe Herrera (Unidad Académica de Medicina Preventiva y Social. Facultad de Medicina, Universidad de la República, Montevideo, Uruguay) V Virginia Suaya (Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay) I Ivan Lyra-Gonzalez (Departamento de Oncologia Clinica, Hospital de Clinicas, Universidad de la Republica, Montevideo, Uruguay) N Noelia Strazzarino (Hospital de Clinicas, Montevideo, Uruguay) L Lucia Argenzio (Hospital de Clínicas, Montevdeio, Uruguay) J Joaquin Manzanares (Servicio de Oncologia Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay) B Belen Insagaray (Servicio de OncologÍa Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay) D Dahianna Tarde (Servicio de Oncología Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay) L Lujan Cabrera (Hospital Departamental de Soriano "Zoilo A. Chelle", Soriano, Uruguay) J Joselina Ibarburu (Hospital Departamental de Soriano "Zoilo A. Chelle", Soriano, Uruguay) G Gabriel David Krygier (Hospital de Clinicas, Montevideo, Uruguay)

Abstract

e24101 Background: Fear of cancer recurrence (FCR) is one of the most frequent and least addressed concerns among patients in oncological follow-up. Its impact on quality of life and emotional well-being has been widely documented, but its systematic evaluation and management in clinical practice remain insufficient. Objective: To assess the prevalence of FCR in a cohort of patients in oncological follow-up and to analyze its association with sociodemographic and clinical variables. Additionally, to explore the interaction between patients and oncologists regarding FCR, focusing on doctor–patient communication and support during consultations. Methods: Cross-sectional study using the Cancer Worry Scale and a structured questionnaire that inquired about doctor–patient dialogue, strategies provided, and desired support. A total of 153 patients in cancer follow-up were included, excluding those under active treatment. Bivariate analyses were performed according to age, educational level, sex, stage, tumor site, and time since diagnosis. Results: A total of 153 patients were included (median age 66 years, 53.6% women). According to the CWS, 26.1% showed high FCR, 29.4% moderate, and 44.4% low. High FCR was more frequent in younger patients, those with higher educational level, advanced stage, and shorter time since diagnosis (p < 0.05). Nearly half (48.4%) discussed FCR with their oncologist, and 15.7% did so in more than one consultation; among those who did not address it, the main reason was not considering it a problem (65.8%). High FCR was associated with lack of opportunity during consultation and with medical strategies perceived as not useful. Conclusions: FCR is frequent among patients in oncological follow-up and is more closely related to sociodemographic than clinical factors. Doctor–patient communication plays a central role in its management. These findings highlight the need for systematic evaluation and support strategies tailored to each patient’s profile, in order to provide more equitable and person-centered care.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (14)

N

Natalia Camejo

Servicio de Oncologia Clinica, Hospital de Clínicas, University of Uruguay, Montevideo, Uruguay

C

Cecilia Castillo

Hospital de Clínicas, Montevideo, Uruguay

D

Dahiana Amarillo

Hospital de Clinicas, Montevideo, Uruguay

G

Guadalupe Herrera

Unidad Académica de Medicina Preventiva y Social. Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

V

Virginia Suaya

Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

I

Ivan Lyra-Gonzalez

Departamento de Oncologia Clinica, Hospital de Clinicas, Universidad de la Republica, Montevideo, Uruguay

N

Noelia Strazzarino

Hospital de Clinicas, Montevideo, Uruguay

L

Lucia Argenzio

Hospital de Clínicas, Montevdeio, Uruguay

J

Joaquin Manzanares

Servicio de Oncologia Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay

B

Belen Insagaray

Servicio de OncologÍa Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay

D

Dahianna Tarde

Servicio de Oncología Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay

L

Lujan Cabrera

Hospital Departamental de Soriano "Zoilo A. Chelle", Soriano, Uruguay

J

Joselina Ibarburu

Hospital Departamental de Soriano "Zoilo A. Chelle", Soriano, Uruguay

G

Gabriel David Krygier

Hospital de Clinicas, Montevideo, Uruguay